Theravance Bio Ord (TBPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
9.50 -0.25 (-2.56%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 9.50 unch (unch) 16:01 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TBPH | VERV | SIGA | ||
| Company | Theravance Bio Ord | Verve Therapeutics Inc | Siga Technologies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.68 | 5.69 | 5.73 | ||
| High | 9.74 | 5.73 | 5.78 | ||
| Low | 9.49 | 5.40 | 5.52 | ||
| Last | 9.50 | 5.46 | 5.76 | ||
| Change | -0.25 | -0.27 | -0.59 | ||
| % Change | -2.56% | -4.71% | -9.29% | ||
| Volume | 223,900 | 2,144,700 | 782,000 | ||
| 20-Day Average Volume | 230,770 | 5,639,005 | 659,625 | ||
| Previous Close | 9.75 | 5.73 | 6.35 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.91 | 4.40 | 5.92 | ||
| 20-Day Raw Stochastic | 84.21% | 80.26% | 48.80% | ||
| 20-Day Relative Strength | 56.38% | 52.32% | 47.36% | ||
| Weighted Alpha | +2.56 | -35.80 | -34.49 | ||
| Today's Opinion | 40% Buy | 56% Sell | 72% Sell | ||
| Previous Opinion | 40% Buy | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 8% Buy | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.04% since 04/22/25 | +4.00% since 04/22/25 | -6.04% since 04/22/25 | ||
| Low | 9.30 on 04/23/25 | 5.37 on 04/24/25 | 5.52 on 04/29/25 | ||
| High | 9.80 on 04/28/25 | 6.10 on 04/28/25 | 6.61 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +2.93% since 03/28/25 | +4.60% since 03/28/25 | +3.78% since 03/28/25 | ||
| Low | 7.90 on 04/07/25 | 2.86 on 04/09/25 | 4.95 on 04/04/25 | ||
| High | 9.80 on 04/28/25 | 6.10 on 04/28/25 | 6.61 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | -1.35% since 01/29/25 | -29.09% since 01/29/25 | -7.99% since 01/29/25 | ||
| Low | 7.90 on 04/07/25 | 2.86 on 04/09/25 | 4.95 on 04/04/25 | ||
| High | 10.19 on 02/27/25 | 9.31 on 02/18/25 | 6.61 on 04/28/25 | ||
| 6-Month | |||||
| %Chg | +9.83% since 10/29/24 | -8.85% since 10/29/24 | -18.99% since 10/29/24 | ||
| Low | 7.90 on 04/07/25 | 2.86 on 04/09/25 | 4.95 on 04/04/25 | ||
| High | 10.90 on 01/24/25 | 9.31 on 02/18/25 | 7.97 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 487,510 | 508,801 | 453,650 | ||
| Shares Outstanding, K | 50,001 | 88,796 | 71,441 | ||
| Annual Sales | 64,380,000 | 32,330,000 | 138,720,000 | ||
| Annual Net Income | -56,420,000 | -198,710,000 | 59,210,000 | ||
| Last Quarter Sales | 18,750,000 | 13,080,000 | 81,470,000 | ||
| Last Quarter Net Income | -15,530,000 | -50,040,000 | 45,760,000 | ||
| 60-Month Beta | 0.14 | 1.86 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 02/26/25 | -0.58 on 02/27/25 | 0.63 on 03/11/25 | ||
| Latest Earnings Date | 05/08/25 | 05/14/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 7.93 | ||